Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03987672 · ClinicalTrials.gov registry record · NA
Study to Intervene With Nutrition for Gastroparesis
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03987672: Clinical Trial NA study, sponsored by Stanford University.
NCT03987672 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03987672, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The study is a self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional diet regimen.
Interventions
- DIETARY_SUPPLEMENT Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2022-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03987672
The ClinicalTrials.gov registry entry for NCT03987672 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula is the first listed.
NCT03987672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03987672 about?
NCT03987672 is a clinical study titled "Study to Intervene With Nutrition for Gastroparesis". The study is a self-controlled study in which we will assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula in patients with gastroparesis, relative to their pre-enrollment nutritional diet regimen.
What is the current status of trial NCT03987672?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-08-01. Estimated completion is 2022-08-18.
What interventions are being tested in trial NCT03987672?
The interventions under investigation include: Assess the nutritional effects of the Kate Farm Peptide 1.5 nutritional Formula (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03987672?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.